Advertisement
Organisation › Details
Biohit (Group)
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. *
Start | 1988-01-01 established | |
Industry | diagnostics (medical/biological) | |
Industry 2 | liquid handling technology | |
Person | Hahtela, Jussi (Biohit 202209– CEO joined as CFO 202106 before Nordea) | |
Region | Helsinki | |
Country | Finland | |
Street | 1 Laippatie | |
City | 00880 Helsinki | |
Tel | +358-9-773-861 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | B: 11 to 50 (2013-04-18) |
Currency | EUR | |
Annual sales | 2,000,000 (net sales (2012) 2012-12-31) | |
* Document for »About Section«: Biohit Oyj. (9/2/22). "Press Release: Change of CEO at Biohit Oyj". | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Biohit (Group)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top